Literature DB >> 31302804

Circular RNAs in β-cell function and type 2 diabetes-related complications: a potential diagnostic and therapeutic approach.

Hassan Ghasemi1, Zolfaghar Sabati2, Hamid Ghaedi3, Zaker Salehi4, Behnam Alipoor5.   

Abstract

Recent investigations have indicated that altered expression of non-coding RNAs (ncRNAs) could be associated with human diseases such as type 2 diabetes (T2D). Circular RNAs (circRNAs) are a new discovered class of ncRNAs with unique structural characteristics that involved in several molecular and cellular functions. Exploring of the circulating circRNAs as a reliable non-invasive biomarker for monitoring and diagnosing of human diseases has grown significantly. However, the molecular functions and clinical relevance of circRNAs are not yet well clarified in T2D. Accordingly, in this review, the involvement of circRNAs in the β-cell function and T2D-related complications is highlighted. The study also shed light on the possibility of using circRNAs as a biomarker for T2D diagnosis.

Entities:  

Keywords:  Biomarkers; Circular RNAs; Complications; Non-coding RNAs; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31302804     DOI: 10.1007/s11033-019-04937-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  111 in total

Review 1.  Long non-coding RNA: Classification, biogenesis and functions in blood cells.

Authors:  Swati Dahariya; Indira Paddibhatla; Santosh Kumar; Sanjeev Raghuwanshi; Adithya Pallepati; Ravi Kumar Gutti
Journal:  Mol Immunol       Date:  2019-05-09       Impact factor: 4.407

Review 2.  Targeting noncoding RNAs in disease.

Authors:  Brian D Adams; Christine Parsons; Lisa Walker; Wen Cai Zhang; Frank J Slack
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

Review 3.  Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.

Authors:  Mariana Murea; Lijun Ma; Barry I Freedman
Journal:  Rev Diabet Stud       Date:  2012-05-10

4.  Resistance training and hawthorn extract ameliorate cognitive deficits in streptozotocin-induced diabetic rats.

Authors:  Ebrahim Zarrinkalam; Kamal Ranjbar; Iraj Salehi; Nejat Kheiripour; Alireza Komaki
Journal:  Biomed Pharmacother       Date:  2017-11-06       Impact factor: 6.529

5.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.

Authors:  K Ogurtsova; J D da Rocha Fernandes; Y Huang; U Linnenkamp; L Guariguata; N H Cho; D Cavan; J E Shaw; L E Makaroff
Journal:  Diabetes Res Clin Pract       Date:  2017-03-31       Impact factor: 5.602

Review 6.  Non-coding RNAs as drug targets.

Authors:  Masayuki Matsui; David R Corey
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

7.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

8.  The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.

Authors:  B Alipoor; H Ghaedi; R Meshkani; M D Omrani; Z Sharifi; T Golmohammadi
Journal:  J Endocrinol Invest       Date:  2017-10-22       Impact factor: 4.256

9.  Non-coding RNA: what is functional and what is junk?

Authors:  Alexander F Palazzo; Eliza S Lee
Journal:  Front Genet       Date:  2015-01-26       Impact factor: 4.599

Review 10.  Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Azra Ramezankhani; Hadi Harati; Mohammadreza Bozorgmanesh; Maryam Tohidi; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-16
View more
  1 in total

Review 1.  Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review.

Authors:  Fariba Dehghanian; Zahra Azhir; Sheyda Khalilian; Björn Grüning
Journal:  J Diabetes Investig       Date:  2021-12-14       Impact factor: 4.232

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.